Project Number PTCG-20-695184 Agency/Funding Organization Alzheimer's Association Funding Year 2020 View Full Project Details for Phase 2 Trial of Rapamycin for Alzheimer's Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) t. Other Researcher and Organization Principal Investigator SESHADRI, SUDHA Principal Investigator First Name SUDHA Principal Investigator Last Name SESHADRI Awardee Organization University of Texas Health Science Center at San Antonio (UT Health San Antonio) Awardee State Texas Contact PI Country United States Project Detail FY Overall Cost $2,073,529 Funding Organization Agency/Funding Organization Alzheimer's Association Funding Organization Country United States Program Official Alzheimer Association
